The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals' Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 ...

According to Benzinga Pro, Baidu's peer group average for short interest as a percentage of float is 8.93%, which means the ...